Journal of Evidence-Based Medicine 2007 Issue 1 xun zheng yi xue gao yue

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Journal of Evidence-Based Medicine
1671-5144
2007 Issue 1

xun zheng yi xue gao yue

..............page:65

xun zheng yi xue za zhi zheng gao zheng ding tong zhi

..............page:6

Lung Mass with A Production of Purulent Sputum
Cancer Center of Guangdong Provincial People's Hospital;Guangdong Provincial Lung Cancer Research Institute

..............page:61-64

The Relationship of Macrophage Migration Inhibitory Factor (MIF) and Dyslipidemia in Type 2 Diabetes Patients
CHEN Hong-mei;LIN Qiu-xiong;YU Xi-yong;CHEN Zhong;KUANG Jian;YANG Hua-zhang

..............page:58-60

The Feature of TCR-Zeta Chain Expression in Patients with Acute Myeloid Leukemia
CHEN Si;LI Yang-qiu;CHEN Shao-hua;YANG Li-jian;WU Xiu-li;CEN Dong-zhi

..............page:54-57

NCCN Distress Management Practice Guidelines
CHU Qian;YU Shi-ying

..............page:38-53

Assessment of the Molecular Classfication of Diffuse Large B-Cell Lymphoma by Immunohistochemistry Using A Tissue Microarray
LIU Yan-hui;DONG Qiu-mei

..............page:18-19,22

Two-Weekly or Three-Weekly CHOP Chemotherapy with or without Etoposide for the Treatment of Young Patients with Good-Prognosis (Normal LDH) Aggressive Lymphomas: Results of the NHL-B1 Trial of the DSHNHL
ZHU Jun

..............page:15-17

CHOP-Like Chemotherapy Plus Rituximab Versus CHOP-Like Chemotherapy Alone in Young Patients with Good-Prognosis Diffuse Large-B-Cell Lymphoma: A Randomised Controlled Trial by the MabThera International Trial (MINT) Group
SHEN Zhi-xiang;LI Wen-yu

..............page:11-14,17

Assessment of the Treatment for Advanced Follicular Lymphoma at MD Anderson Cancer Center over 25 Years
LIN Tong-yu;DONG Qiu-mei

..............page:7-10

The Research Advances on Treatment of Non-Hodgkin's Lymphoma
JIANG Wen-qi

..............page:2-6

New Target Therapy for HER2-Positive Advanced Breast Cancer
WU Yi-long

..............page:1

FDA Alert:Cancer Patients Should Use Erythropoiesis-Stimulating Agent with Caution
WU Yi-long

..............page:1

Tracing Epidermal Growth Factor Receptor Mutations in Lung Cancer with "Web of Science"
ZHONG Wen-zhao;GU Li-jia;GUO Ai-lin;YANG Xue-ning;WU Yi-long

..............page:33-37

From the Evidence-Based Medicine to Evidence-Based Practice
YIN Zhao-fang;WU Shi-yao

..............page:31-32

Evidence-Based Medical Treatment for Idiopathic Sudden Sensorineural Hearing Loss
HUANG Jin-zhong;TANG An-zhou;YIN Shi-hua;XU Zhi-wen;SU Ji-ping;ZHOU Yong

..............page:26-30

Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients with Diffuse Large B-Cell Lymphoma——A Study by the Groupe d'Etude des Lymphoma de l'Aduite
HUANG Hui-qiang;CAI Qing-qing

..............page:23-25,57

Evaluation of the Rituximab Maintenance Improves Clinical Outcome of Relapsed/Resistant Follicular Non Hodgkin's Lymphoma, Both in Patients with and without Rituximab during Induction: Results of A Prospective Randomized Phase Ⅲ Intergroup Trial
XIA Zhong-jun;LI Wen-yu

..............page:20-22